Key indicators: single-crystal X-ray study; T = 295 K; mean (C-C) = 0.004 Å; R factor = 0.055; wR factor = 0.144; data-to-parameter ratio = 15.8.
The benzimidazolone part of the molecule of the title compound, C 15 H 21 N 3 O 3 , is almost planar (r.m.s. deviation = 0.007 Å ) with its mean plane aligned at a dihedral angle of 10.4 (3) with respect to the mean plane of the nitro substituent. In the crystal, two molecules are disposed about a center of inversion, generating an N-HÁ Á ÁO hydrogenbonded cyclic dimer with R 2 2 (8) graph-set motif.
Related literature
For the crystal structure of 1-isopropenyl-1H-benzimidazol-2(3H)-one, see: Saber et al. (2010) . For graph-set notation, see: Etter (1990 Table 1 Hydrogen-bond geometry (Å , ).
Symmetry code: (i) Àx þ 1; Ày þ 1; Àz þ 1.
Data collection: APEX2 (Bruker, 2005); cell refinement: SAINT (Bruker, 2005); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: X-SEED (Barbour, 2001); software used to prepare material for publication: publCIF (Westrip, 2010).
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Comment
Tetraalkylammonium halides are used as phase-transfer catalyst in the synthesis of alkyl-substituted benzimidazolones. A previous study reported the 1-isopropenyl derivative; the amino -NH unit forms a hydrogen bond to the inversion-related molecule to generate a hydrogen-bonded dimer (Saber et al., 2010) . The present compound (Scheme I) features a long n-octyl chain that adopts an extended zigzag conformation (Fig. 1) . The benzimidazolone part of the C 15 H 21 N 3 O 3 molecule is planar (r.m.s. deviation 0.007 Å) and its mean plane is aligned at 10.4 (3) ° with respect to the mean plane of the nitro substituent. Two molecules are disposed about a center of inversion to generate a hydrogen-bonded cyclic dimer, whose hydrogen-bonding motif is described by the R 2 2 (8) graph set (Etter, 1990) .
Experimental
To 5-nitro-1H-benzoimidazol-2(3H)-one (0.2 g, 1.1 mmol), potassium carbonate (0.30 g, 2.2 mmol) and tetra-n-butylammonium bromide (0.07 g, 0.2 mmol) in DMF (15 ml) was added 1-bromo-n-octane (0.38 ml, 2.2 mmol). Stirring was continued at room temperature for 6 h. The salt was removed by filtration and the filtrate concentrated under reduced pressure.
The residue was separated by chromatography on a column of silica gel with ethyl acetate/hexane (1/2) as eluent. The compound was recrystallized from diethyl ether to give colorless crystals.
Refinement
Carbon-bound H-atoms were placed in calculated positions (C-H 0.93-0.97 Å) and were included in the refinement in the riding model approximation, with U iso (H) set to 1.2-1.5U eq (C). (3) Symmetry codes: (i) −x+1, −y+1, −z+1. Fig. 1 
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